Trident Texofab Limited (BOM:540726)
India flag India · Delayed Price · Currency is INR
22.82
+0.68 (3.07%)
At close: Aug 21, 2026

Trident Texofab Statistics

Total Valuation

Trident Texofab has a market cap or net worth of INR 342.20 million. The enterprise value is 707.67 million.

Market Cap342.20M
Enterprise Value 707.67M

Important Dates

The last earnings date was Monday, August 10, 2026.

Earnings Date Aug 10, 2026
Ex-Dividend Date n/a

Share Statistics

Trident Texofab has 15.00 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class 15.00M
Shares Outstanding 15.00M
Shares Change (YoY) +0.59%
Shares Change (QoQ) -3.55%
Owned by Insiders (%) 40.98%
Owned by Institutions (%) n/a
Float 8.67M

Valuation Ratios

The trailing PE ratio is 143.62.

PE Ratio 143.62
Forward PE n/a
PS Ratio 0.29
PB Ratio 0.62
P/TBV Ratio 0.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 336.19
EV / Sales 0.61
EV / EBITDA 15.63
EV / EBIT 24.46
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.66
Debt / EBITDA 8.10
Debt / FCF -3.61
Interest Coverage 1.05

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 1.10%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 1.09%
Revenue Per Employee 18.43M
Profits Per Employee 33,413
Employee Count63
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Trident Texofab has paid 3.90 million in taxes.

Income Tax 3.90M
Effective Tax Rate 64.95%

Stock Price Statistics

The stock price has decreased by -89.61% in the last 52 weeks. The beta is -0.87, so Trident Texofab's price volatility has been lower than the market average.

Beta (5Y) -0.87
52-Week Price Change -89.61%
50-Day Moving Average 31.04
200-Day Moving Average 127.80
Relative Strength Index (RSI) 34.45
Average Volume (20 Days) 35,691

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Trident Texofab had revenue of INR 1.16 billion and earned 2.11 million in profits. Earnings per share was 0.16.

Revenue1.16B
Gross Profit 109.84M
Operating Income 28.93M
Pretax Income 6.01M
Net Income 2.11M
EBITDA 45.26M
EBIT 28.93M
Earnings Per Share (EPS) 0.16
Full Income Statement

Balance Sheet

The company has 1.12 million in cash and 366.59 million in debt, with a net cash position of -365.47 million or -24.37 per share.

Cash & Cash Equivalents 1.12M
Total Debt 366.59M
Net Cash -365.47M
Net Cash Per Share -24.37
Equity (Book Value) 555.82M
Book Value Per Share 35.96
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -96.36 million and capital expenditures -5.16 million, giving a free cash flow of -101.52 million.

Operating Cash Flow -96.36M
Capital Expenditures -5.16M
Depreciation & Amortization 16.34M
Net Borrowing 68.40M
Free Cash Flow -101.52M
FCF Per Share -6.77
Full Cash Flow Statement

Margins

Gross margin is 9.46%, with operating and profit margins of 2.49% and 0.18%.

Gross Margin 9.46%
Operating Margin 2.49%
Pretax Margin 0.52%
Profit Margin 0.18%
EBITDA Margin 3.90%
EBIT Margin 2.49%
FCF Margin n/a

Dividends & Yields

Trident Texofab does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.59%
Shareholder Yield -0.59%
Earnings Yield 0.62%
FCF Yield -29.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 11, 2020. It was a forward split with a ratio of 2.4.

Last Split Date Aug 11, 2020
Split Type Forward
Split Ratio 2.4

Scores

Altman Z-Score n/a
Piotroski F-Score 1